Cogent Biosciences (COGT) earnings, Jul 28, 2026: EPS +12%, stock +0.6%
In brief
Cogent Biosciences reported on Jul 28, 2026. Earnings per share changed +12% year over year, 1.6% below the estimate; revenue 0%. The stock opened with a +0.2% gap and closed the day +0.6% (Jul 28, 2026). The stock is now 32.4% below its 52-week high, +105.1% over 12 months. Next report: Nov 10, 2026.
EPS vs estimate−1.6%
EPS, YoY+12%
Revenue, YoY0%
Gap · day+0.2% · +0.6%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| May 5, 2026 | +0.5% | +0.7% |
| Jun 30, 2026 | −0.3% | −0.6% |
| Jul 28, 2026 | +0.2% | +0.6% |
Next-quarter estimates, ratings and the COGT chart are in the terminal.
Open the terminalFAQ
When is Cogent Biosciences's next earnings report?
Nov 10, 2026. The date comes from daily data and is corrected if the company moves it.
How did Cogent Biosciences stock react to the report?
Opening gap +0.2%, day's result +0.6%.
Did Cogent Biosciences's earnings grow?
Earnings per share rose 12% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.